Mycodern S.A.
Mycodern S.A., a technology company, engages in the provision of solutions for the collection of libraries and archives, materials for forensics, production of graphic media, sale of exhibition systems, and development of machinery technology for production systems in Poland. The company offers graphic media, including media, laminates, glues, berger fabric, and laminotrs; and libraries, such as … Read more
Mycodern S.A. (GY3) - Total Assets
Latest total assets as of September 2025: €4.52 Million EUR
Based on the latest financial reports, Mycodern S.A. (GY3) holds total assets worth €4.52 Million EUR as of September 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Mycodern S.A. - Total Assets Trend (2021–2024)
This chart illustrates how Mycodern S.A.’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Mycodern S.A. - Asset Composition Analysis
Current Asset Composition (December 2024)
Mycodern S.A.'s total assets of €4.52 Million consist of 95.3% current assets and 4.7% non-current assets.
| Asset Category | Amount (EUR) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | €0.00 | 0.3% |
| Accounts Receivable | €1.20 Million | 26.1% |
| Inventory | €350.00K | 7.6% |
| Property, Plant & Equipment | €0.00 | 0.0% |
| Intangible Assets | €0.00 | 0.0% |
| Goodwill | €0.00 | 0.0% |
Asset Composition Trend (2021–2024)
This chart illustrates how Mycodern S.A.'s asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Mycodern S.A.'s current assets represent 95.3% of total assets in 2024, an increase from 0.0% in 2021.
- Cash Position: Cash and equivalents constituted 0.3% of total assets in 2024, up from 0.0% in 2021.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2021.
- Asset Diversification: The largest asset category is accounts receivable at 26.1% of total assets.
Mycodern S.A. Competitors by Total Assets
Key competitors of Mycodern S.A. based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
General Mills Inc
NYSE:GIS
|
USA | $32.55 Billion |
|
B&G Foods Inc
NYSE:BGS
|
USA | $2.94 Billion |
|
Tangrenshen Group Co Ltd
SHE:002567
|
China | CN¥17.90 Billion |
|
Shenzhen Shenbao Industrial Co Ltd
SHE:000019
|
China | CN¥7.01 Billion |
|
Xiwang Foodstuffs Co Ltd
SHE:000639
|
China | CN¥6.08 Billion |
|
Nanfang Black Sesame Group Co Ltd
SHE:000716
|
China | CN¥4.57 Billion |
|
CNFC Overseas Fishery Co Ltd
SHE:000798
|
China | CN¥5.88 Billion |
|
Henan Shuanghui Investment & Development Co Ltd
SHE:000895
|
China | CN¥40.64 Billion |
Mycodern S.A. - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Moderate asset utilization - Mycodern S.A. generates 0.46x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - Mycodern S.A. is currently not profitable relative to its asset base.
Mycodern S.A. - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 3.38 | 3.40 | 3.40 |
| Quick Ratio | 3.10 | 3.13 | 3.13 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | €3.04 Million | € 3.11 Million | € 3.11 Million |
Mycodern S.A. - Advanced Valuation Insights
This section examines the relationship between Mycodern S.A.'s asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | - |
| Latest Market Cap to Assets Ratio | 1.32 |
| Asset Growth Rate (YoY) | -85.4% |
| Total Assets | €4.61 Million |
| Market Capitalization | $6.11 Million USD |
Valuation Analysis
Above Book Valuation: The market values Mycodern S.A.'s assets above their book value (1.32 x), reflecting positive investor sentiment about the company's future prospects.
Significant Asset Reduction: Mycodern S.A.'s assets decreased by 85.4% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Mycodern S.A. (2021–2024)
The table below shows the annual total assets of Mycodern S.A. from 2021 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | €4.61 Million | -85.39% |
| 2023-12-31 | €31.58 Million | +14.04% |
| 2022-12-31 | €27.69 Million | -- |
| 2021-12-31 | €0.00 | -- |